Skip to main content
Premium Trial:

Request an Annual Quote

Mike Wilkins, Steven Casey, Bill Bullock, David Duncan, Kelly Smith, Austin Beggs, Jackie Kerby Moore, Bruce Wright, Rasesh Thakkar, Christine Garvey, Jeff Ghannam, Sylvia Aguilera, David Mott, John Minervini

Premium

NC Biotech Center Taps Speaker’s Aide, Names Two New Vice Presidents
 
Mike Wilkins has joined the North Carolina Biotechnology Center as senior vice president of statewide operations and economic development. Wilkins will lead the center’s new statewide operations and economic development division, formed to foster the creation and growth of biotechnology companies, business development and new job opportunities throughout the state.
 
In his newly created position, Wilkins, 62, will oversee the Biotechnology Center’s five regional offices, five regional biotechnology advisory committees and worldwide economic development activities. Wilkins will oversee a staff of 15 and report to the biotech center’s president and CEO Norris Tolson.
 
A native of Roxboro, NC, Wilkins was previously senior policy advisor to North Carolina House of Representatives Speaker Joe Hackney and served three consecutive two-year terms in the NC House from 1992-98, serving District 22. Earlier he was founder and chief operating officer of Convenience Corner, a Roxboro company with real estate, restaurants, convenience stores and car washes in central North Carolina.  He has a bachelor’s degree in business administration from the University of North Carolina-Chapel Hill and served four years as a captain in the US Air Force.
 
The center has also promoted Steven Casey to vice president of statewide development; and Bill Bullock to vice president of bioscience industrial development.
 
Casey, 50, joined the biotechnology center in August 2006 as business development director. Previously he was founder and chief operating officer of Expression Analysis, a Durham company that provides gene expression, genotyping and re-sequencing services for pharmaceutical and biotechnology companies. Before that he was a manager with the Howard Hughes Medical Institute at Duke University after being discharged with honors from two decades of service with the US Air Force. He has a bachelor’s degree in business administration from Wayland Baptist University and an MBA from Elon College.
 
Bullock, 46, previously the center’s director of bioscience industrial development, has had two stints at the Biotechnology Center, the most recent one a joint position with the state Department of Commerce starting in July 2002. Previously he spent eight years as vice president of BioAbility, a bioscience consulting firm in Research Triangle Park. He also held production, marketing and technical jobs at Stratagene Cloning Systems of San Diego for six years. He has a bachelor’s degree in biochemistry and cell biology from the University of California-San Diego and an MBA from UNC-Chapel Hill.
 

 
Pasteuria Bioscience Names New CEO, Shifts Predecessor to CTO Position
 
David Duncan has been named CEO of Pasteuria Bioscience, a developer of biological control products for plant-parasitic nematodes, and has also been elected to the company's board of directors. He succeeds Kelly Smith, who will remain with the company as its chief technology officer. Pasteuria Bioscience is located at the University of Florida's Sid Martin Biotechnology Incubator in Alachua, Fla.
 
Duncan previously served as CEO of Chlorogen, a startup focused on human therapeutic protein expression and production in tobacco. The company is on pace to file a submission for registration to EPA by mid-2008. Earlier he held positions in product development, marketing, government and regulatory affairs at Monsanto, where he led its turf and ornamental business and the development of Dimension turf herbicide.
 
Duncan received degrees at Indiana State and Michigan State universities.
 

 
AURP Honors Two Past Presidents, Two Tech Campus Veterans
 
The Association of University Research Parks honored two past board presidents and two technology campus veterans during the closing luncheon of its 2007 annual conference, held Oct. 26 at the Chase Park Plaza hotel.
 
Austin Beggs, immediate past president; and Jackie Kerby Moore, an AURP board member and president from 2005-06; received distinguished service awards. Beggs is director of corporate relations for the Innovation Place research park in Saskatoon, Saskatchewan, Canada; while Kerby Moore is executive director of the Sandia Science & Technology Park in Albuquerque, NM.
 
AURP also announced two individual honors:
  • Career achievement award — Bruce Wright, associate vice president for economic development, University of Arizona in Tucson. His duties include directing the University of Arizona Science and Technology Park as well as the university’s offices of economic development and economic and policy analysis.
  • Community leadership — Rasesh Thakkar, senior managing director of the Tavistock Group, developer of the 7,000-acre Lake Nona, a $2 billion master-planned community being developed within Orlando, Fla. Burnham Institute for Medical Research broke ground Oct. 3 on an $80 million, 175,000-square-foot facility there.

 
Deutsche Bank Consultant, Ex-Real Estate Head, Elected to HCP’s Board of Directors
 
Christine Garvey has been elected to the board of directors of HCP, the Long Beach, Calif., real estate investment trust that earlier this year snapped up the US life sciences portfolio of British-owned Slough Estates Group [See related story, this issue]. Garvey’s election brings HCP’s board to 11 members, nine of which are independent. Garvey’s election brings HCP’s board to 11 members, nine of which are independent.
 
Garvey is a consultant to Deutsche Bank and served as its global head of corporate real estate services from 2001 to 2004. Earlier, she served as vice president of worldwide real estate and workplace resources at Cisco Systems, and as group executive vice president at Bank of America.
 
Garvey is also a member of the board of trustees of ProLogis since September 2005, when Catellus Development Corporation merged into a subsidiary of ProLogis; she had been a member of Catellus’ board since 1995. Garvey is also a board member of UnionBanCal Corporation, and served on the board of directors of Hilton Hotels until October 2007.
 

 
Biotech Institute Executive, PhaRMA Counsel Elected to PRSA-NCC Board
 
Jeff Ghannam, communications director of the Biotechnology Institute in Arlington, Va., has been elected treasurer of the Public Relations Society of America-National Capital Chapter, the nation’s largest PRSA chapter with nearly 1,100 members. In addition, Sylvia Aguilera, counsel, global alliance development, Pharmaceutical Research and Manufacturers of America, has been elected to a term expiring in 2008 on the chapter’s board of directors.
 
PRSA-NCC’s officers, directors and assembly delegates oversee the chapter's more than 50 annual professional development and awards programs designed to advance professionalism and career growth.
 

 
MedImmune CEO and President Named to Shire Board as Non Executive Director
David Mott, the CEOand president of MedImmune and an executive vice president and senior team member of the company’s new owner AstraZeneca, has been appointed to the board of directors of British-owned biopharmaceutical giant Shire as a non executive director.
 
Mott joined MedImmune 1992 and has held positions of increasing responsibility in finance, strategic planning, business development, medical and regulatory including the positions of CFO and COO. He was named to his present position in 2000. MedImmune was acquired by AstraZeneca last June.

Before joining MedImmune, Mott was a vice president in the healthcare investment banking group at Smith Barney Harris Upham and Company.

Mott is a member of the board of directors of Rib-X Pharmaceuticals and also serves on the Boards of Directors of the Biotechnology Industry Organization and the Technology Council of Maryland and its MdBio division. He holds a bachelor’s degree in economics and government from Dartmouth College.

 

 
Cushman & Wakefield Promotes Global Life Science Managing Principal to Executive Director
 
John Minervini, a managing principal of Cushman & Wakefield’s Global Life Science Practice Group, has been promoted to executive director.  He was previously a senior director based in the global commercial real estate brokerage firm’s Los Angeles downtown office.
 
The global life science practice group offers specialized services to the life sciences industry for acquisitions, dispositions and structured finance. Minervini is one of four managing principals of the group, which was formed this past summer [BioRegion News, July 30]. 
 
Minervini joined C&W in 1985 and has represented the real estate interests of major corporations throughout the United States, Europe, the Middle East, Africa, and Asia.  Among his most notable assignments have been the worldwide exclusive listing for transactional real estate awarded to his team in 1997 by Bausch & Lomb; the appointment as the North America account director for TEVA Pharmaceutical’s real estate interests, following the selection of C&W as the firm’s global preferred provider; and a global preferred provider agreement with Merck awarded in 2000.
 
A consistent recipient of C&W’s Chairman’s Circle award, Minervini is a graduate of the University of California at Davis with a degree in fermentation science, a board member of the Dolores Mission School in Boyle Heights, Los Angeles; and a board member of the Uhlmann Offices, a diversified real estate investment company.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.